Neonate Abstinence Syndrome, intervention
The impact of drug use by mothers to fetus’ in utero is critical not only to their growth and development but also has huge implications for sudden withdrawal at birth. Medication is used for neonates along with many other therapeutic techniques. With drug use for pregnant mothers rising, the incidence for NAS is significant. Hospitals are faced with lengthy hospital stays for neonates as well as providing environments appropriate for these newborns. Neonatal Abstinence Syndrome has risen in opioid dependency alone from 26.4% in 2000 to 41.7% in 2008. As national drug use is increasing, Neonatal Abstinence Syndrome (NAS) congruently is as well.
Danner, Erica, "Neonate Abstinence Syndrome and Therapeutic Interventions" (2012). Pharmacy and Nursing Student Research and Evidence-Based Medicine Poster Session. 26.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.